RhumbLine Advisers’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.75M | Buy |
|
|||||
|
2025
Q2 | $1.62M | Buy |
|
|||||
|
2025
Q1 | $2.08M | Buy |
|
|||||
|
2024
Q4 | $2.36M | Sell |
|
|||||
|
2024
Q3 | $2.55M | Buy |
|
|||||
|
2024
Q2 | $2.79M | Sell |
|
|||||
|
2024
Q1 | $2.47M | Buy |
|
|||||
|
2023
Q4 | $2.52M | Sell |
|
|||||
|
2023
Q3 | $3.44M | Buy |
|
|||||
|
2023
Q2 | $3.24M | Buy |
|
|||||
|
2023
Q1 | $1.68M | Buy |
|
|||||
|
2022
Q4 | $1.41M | Buy |
|
|||||
|
2022
Q3 | $935K | Buy |
|
|||||
|
2022
Q2 | $1.36M | Sell |
|
|||||
|
2022
Q1 | $2.18M | Buy |
|
|||||
|
2021
Q4 | $1.4M | Sell |
|
|||||
|
2021
Q3 | $1.76M | Sell |
|
|||||
|
2021
Q2 | $3.18M | Buy |
|
|||||
|
2021
Q1 | $2.29M | Buy |
|
|||||
|
2020
Q4 | $1.94M | Buy |
|
|||||
|
2020
Q3 | $1.03M | Buy |
|
|||||
|
2020
Q2 | $1.33M | Sell |
|
|||||
|
2020
Q1 | $736K | Buy |
|
|||||
|
2019
Q4 | $2.68M | Sell |
|
|||||
|
2019
Q3 | $3.44M | Sell |
|
|||||
|
2019
Q2 | $3.92M | Buy |
|
|||||
|
2019
Q1 | $5.14M | Buy |
|
|||||
|
2018
Q4 | $4.34M | Buy |
|
|||||
|
2018
Q3 | $4.38M | Sell |
|
|||||
|
2018
Q2 | $4.86M | Sell |
|
|||||
|
2018
Q1 | $4.19M | Sell |
|
|||||
|
2017
Q4 | $4.6M | Sell |
|
|||||
|
2017
Q3 | $4.27M | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $496K | Buy |
|
|||||
|
2013
Q4 | $363K | Buy |
|
|||||
|
2013
Q3 | $288K | Hold |
|
|||||
|
2013
Q2 | $258K | Buy |
|